Joaquín Arribas, Director of Preclinical Research at VHIO, this week joined 165 of the world´s leading breast cancer researchers in…
news
The Prize, supporting translational research of excellence, was established in memory of the pioneer of cancer research in France, Georges…
VHIO´s Director of Translational Research and Principal Investigator of VHIO´s Gene Expression & Cancer Group, Joan Seoane, and Eduard Batlle, Oncology Programme Coordinator and Director of the Colorectal Cancer Laboratory at the Institute for Research in Biomedicine (IRB Barcelona), share the 2013 Dr. Josef Steiner Cancer Research Award for their research into brain cancer and colon cancer, respectively.
The 2013 Award celebrates cancer research of excellence in Barcelona.
VHIO scientists discover a common factor among different tumours in a patient with Li-Fraumeni syndrome further to whole-genome sequencing This…
Abstract submission and Registration for the VHIO-Fritz Bender Foundation joint International Symposium on Progress Towards Individualized Cancer Treatments, 07 –…
The phase III study, published in the prestigious scientific journal, The Lancet, in which researchers at the Vall d´Hebron University…
Presided by Crown Princess Letizia of Spain, Honorary President of the Spanish Association Against Cancer (AECC), a special Congress entitled…
Amgen today announced the publication of a biomarker analysis of Vectibix® (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based…
Progress Towards Individualized Cancer Treatments 07 – 09 November 2013, marks the 17th International Symposium in the annual series of…
Officially announced today, Halaven ® (Eribulin) has received reimbursement approval from the Spanish Directorate General of Pharmacy and Health Products,…
